Author: Anuj

Precision Medicine: An emerging approach to conventional treatment

Articles

As per WHO, “Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018....

Read More

Algernon’s NP-120; FDA nod to 4DMedical tool; SaNOtize’s NORSTM trial; Pole’s capital increase

Articles

Algernon Pharmaceuticals has announced the submission of an Investigational New Drug (IND) application of its drug, NP-120 for...

Read More

Keeping a track on COVID-19 through Wearable Technology

Articles

COVID-19 is here and is not vanishing anytime soon from our lives as suggested by health bodies, scientists, and researchers. It’s almost...

Read More

Moderna’s COVID-19 Vaccine; Quidel’s Lyra gets EUA from FDA; Neurotrope and Metuchen Pharma Announced Merger Agreement; FDA Approval to Rucaparib;

Articles

Moderna Therapeutics has announced the positive results of trials of its COVID-19 vaccine, mRNA-1273.   The results of interim Phase...

Read More

Security Breach: A Growing Concern For The Healthcare Industry

Articles

Telehealth and online medical services have accorded many opportunities for healthcare professionals and patients around the world. A...

Read More

Mavacamten Phase III clinical trial, FDA nod for Ovarian cancer therapy, Dyno Therapeutics & Novartis Collaboration, Abbott’s COVID-19 diagnostic kit

News

MyoKardia has announced the promising results of Phase III clinical trials of its lead drug mavacamten for symptomatic, obstructive...

Read More
Close